miR-363 Alleviates Detrusor Fibrosis via the TGF-β1/Smad Signaling Pathway by Targeting Col1a2 in Rat Models of STZ-Induced T2DM.

Li XF, Zhang SH, Liu GF, Yu SN

Open source

DOI
10.1016/j.omtn.2020.07.001
Published
2020 Dec 4
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2020.07.001,
  title = {miR-363 Alleviates Detrusor Fibrosis via the TGF-β1/Smad Signaling Pathway by Targeting Col1a2 in Rat Models of STZ-Induced T2DM.},
  author = {Li XF and Zhang SH and Liu GF and Yu SN},
  year = {2020},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2020.07.001},
  url = {https://doi.org/10.1016/j.omtn.2020.07.001}
}

RIS

TY  - JOUR
TI  - miR-363 Alleviates Detrusor Fibrosis via the TGF-β1/Smad Signaling Pathway by Targeting Col1a2 in Rat Models of STZ-Induced T2DM.
AU  - Li XF
AU  - Zhang SH
AU  - Liu GF
AU  - Yu SN
PY  - 2020
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2020.07.001
UR  - https://doi.org/10.1016/j.omtn.2020.07.001
ER  - 

APA

XF, L., SH, Z., GF, L., & SN, Y. (2020). miR-363 Alleviates Detrusor Fibrosis via the TGF-β1/Smad Signaling Pathway by Targeting Col1a2 in Rat Models of STZ-Induced T2DM.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2020.07.001

Source records